Anxiety News and Research

Latest Anxiety News and Research

AcelRx initiates ARX-01 Phase 3 study for treatment of post-operative pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, reported dosing of the first patient in a Phase 3 study for ARX-01, the Sufentanil NanoTab PCA System, its novel sublingual patient-controlled analgesia system.

6 Mar 2012

Almost 70% of young adults with Asperger syndrome have suffered from depression

Given that almost 70% of young adults with Asperger syndrome have suffered from depression, it is vital that psychiatric care staff are aware of this so that patients are given the right treatment, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

6 Mar 2012

Women with breast cancer can benefit from web-based programme

Every day 18 Swedish women are diagnosed with breast cancer. Although there is a real need for support and information, many women struggle and get lost in the deluge of information. In a study of 227 women, researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have developed a web-based programme to guide patients all the way from diagnosis to rehabilitation.

6 Mar 2012

Butler Hospital expands Outpatient Psychiatric Consultation Program

In a move that highlights collaboration across a health care system, three Care New England hospitals recently came together to pilot a service that is now being expanded to fill a need for mental health services in the entire region. After successfully piloting the concept at Women & Infants and Kent hospitals, Butler Hospital is expanding its Outpatient Psychiatric Consultation Program to all referring physicians in the area who may have a patient needing a consult.

6 Mar 2012

Snoring toddlers may develop behavioural problems later: Study

A new study shows that babies and toddlers who snore, gasp for breath, or breathe with their mouth open while sleeping may be at a greater risk of behavioural problems all the way through second grade.

5 Mar 2012

High blood pressure due to stress maybe due to the immune system

If stress is giving you high blood pressure, blame the immune system. T cells, helpful for fighting infections, are also necessary for mice to show an increase in blood pressure after a period of psychological stress, scientists have found.

5 Mar 2012

Tips to assess when gambling could be leading to process addiction

Whether it's a March Madness office betting pool or sitting in the sports books in Las Vegas placing bets on the Masters Golf Tournament and opening week of Major League Baseball, the coming months are fraught with sporting events which lure millions of gamblers to place their bets.

5 Mar 2012

Young children with SDB more likely to develop neurobehavioral problems

A study of more than 11,000 children followed for over six years has found that young children with sleep-disordered breathing are prone to developing behavioral difficulties such as hyperactivity and aggressiveness, as well as emotional symptoms and difficulty with peer relationships, according to researchers at Albert Einstein College of Medicine of Yeshiva University.

5 Mar 2012

Poor neighborhoods linked with worse chronic pain for young adults

Living in a poor neighborhood was linked with worse chronic pain for young adults, according to a study by the University of Michigan Health System, but young black patients faced difficulties with pain management no matter where they lived.

2 Mar 2012

More than 80% of anesthesiologists have been involved in surgical catastrophes

More than 80 percent of anesthesiologists have been involved in a catastrophic event involving death or injury to a patient during surgery, suggests a survey study in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

1 Mar 2012

Inhibitory effect of serotonin 1A receptor is extremely small in people with depression

Researchers at the MedUni Vienna have, for the first time, investigated the influence of the serotonin system on the default mode network (DMN) in the human brain and discovered that, in people with depression, the inhibitory effect of the serotonin 1A receptor is extremely small. This means, says Siegfried Kasper, Head of the University Department of Psychiatry and Psychotherapy, that affected patients "are virtually never able to be mentally calm".

1 Mar 2012

Biogen Idec announces new easier to use injection for multiple sclerosis

The Food and Drug Administration approved the company's Avonex pen, an injection designed to reduce pain and anxiety when patients self-administer the drug. The FDA also approved a new dosing schedule for the drug intended to reduce flu-like symptoms often associated with the drug.

29 Feb 2012

Mantra-based meditation shows promise against age-associated cognitive impairment

Researchers at Thomas Jefferson University Hospital determined that mantra-based meditation can have a positive impact on emotional responses to stress, fatigue and anxiety in adults with memory impairment and memory loss.

29 Feb 2012

First study to show effects of ecstasy drug on fetal and infant development

A study led by Case Western Reserve University School of Medicine, in collaboration with the University of East London UK, and Swansea University UK, is the first to show the effects of the drug ecstasy on fetal and infant development.

29 Feb 2012

Nurses play a key role in alleviating cancer patients' concerns

Often faced with overwhelming anxiety, patients newly diagnosed with lung cancer can find themselves in distress, and new research recommends nurses play a key role in alleviating concerns, leading to a better quality of life for patients.

29 Feb 2012

Biogen Idec receives FDA approval for two separate dosing innovations to treat MS

Today Biogen Idec announced that the U.S. Food and Drug Administration (FDA) has approved two separate dosing innovations designed to improve the treatment experience for patients receiving once-a-week AVONEX for relapsing forms of multiple sclerosis (MS).

28 Feb 2012

Gedeon Richter and Forest Labs' cariprazine Phase III trials on schizophrenia meet primary endpoint

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced positive top-line results in 2 Phase III clinical trials of cariprazine (RGH-188) for the treatment of acute exacerbation of schizophrenia.

28 Feb 2012

Childhood adversity may lead to epigenetic changes in glucocorticoid receptor gene

In a look at how major stressors during childhood can change a person's biological risk for psychiatric disorders, researchers at Butler Hospital have discovered a genetic alteration at the root of the association.

28 Feb 2012

People with depression have increased connections among most brain areas

Most of us know what it means when it's said that someone is depressed. But commonly, true clinical depression brings with it a number of other symptoms. These can include anxiety, poor attention and concentration, memory issues, and sleep disturbances.

27 Feb 2012

State roundup: State tobacco funds scrutinized; More allegations against Calif.'s Prime Healthcare; Ore. CCOs get green light

A U.S. Surgeon General's report due to be released March 8 will come down hard on states that have cut anti-smoking funds in tough fiscal times, said Terry Pechacek, who oversees the report as director for Science in the Office on Smoking and Health at the Centers for Disease Control and Prevention. The report can't result in sanctions, but it has proven to move public opinion in the past to force changes by tobacco companies in how they sell cigarettes, how states fund efforts and how the federal government regulates the trade.

27 Feb 2012